Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

Clayton, Anita H; Lasser, Robert; Nandy, Indrani; Sankoh, Abdul J; Jonas, Jeffrey; Kanes, Stephen J

Clayton, Anita H; Lasser, Robert; Nandy, Indrani; Sankoh, Abdul J; Jonas, Jeffrey; Kanes, Stephen J.

Afiliación

Clayton AH; University of Virginia School of Medicine, Charlottesville, Virginia.
Lasser R; Corresponding author: Anita H. Clayton, MD, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, PO Box 800623, Charlottesville, VA 22908-0623 (ahc8v@hscmail.mcc.virginia.edu).
Nandy I; Sage Therapeutics, Inc, Cambridge, Massachusetts.
Sankoh AJ; Sage Therapeutics, Inc, Cambridge, Massachusetts.
Jonas J; Sage Therapeutics, Inc, Cambridge, Massachusetts.
Kanes SJ; Sage Therapeutics, Inc, Cambridge, Massachusetts.

J Clin Psychiatry ; 84(2)2023 02 20.

Article en En | MEDLINE | ID: mdl-36811520

Asunto(s)

Trastorno Depresivo Mayor; Adulto; Humanos; Trastorno Depresivo Mayor/tratamiento farmacológico; Método Doble Ciego; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: J Clin Psychiatry Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google